A quadruple whammy of viruses – flu, COVID, norovirus, and respiratory syncytial virus, or RSV – is hitting the U.S. as the year comes to a close. The Centers for Disease Control and Prevention has ...

Despite 50 years of research, there are currently no RSV vaccines approved or in Phase III trials for any of the target populations. High levels of neutralizing antibodies to RSV F protein have ...

Now, Scripps Research scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design vaccines that target it. Their research, published in Nature ...

Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you know for sure? Here are the ...

Respiratory syncytial virus (RSV) infections can lead to serious complications, particularly in infants and older adults aged ...

for increased sickness. The winter and holiday season is typically when more people get sick, particularly with respiratory viruses such as the flu, RSV and COVID-19. While most of us have heard ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Though there are now respiratory syncytial virus (RSV) vaccines approved by the FDA and recommended by the CDC for ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs. According to the ...

SANTA MARIA, Calif. -- Respiratory Syncytial Virus (RSV) is a common virus that typically causes mild cold-like symptoms in healthy adults and older children. However, for certain populations ...